Sensex Today | Stock Market LIVE Updates: Sun Pharma Advanced Research decides to close proseek study of Vodobatinib 

SPARC announces results from planned interim analysis of proseek study of Vodobatinib in patients with early parkinson's disease

SPARC has decided to close ongoing proseek study

SPARC has reviewed data and determined that study has not shown evidence of treatment benefit in patients receiving Vodobatinib

Plans to complete full analysis of clinical outcomes and correlative biomarker data in coming months